Buy Zimelidine (Zimeldine) Cas 56775-88-3

+ Free Shipping
Guaranteed Safe Checkout

Buy Zimelidine (Zimeldine) Cas 56775-88-3

Buy Zimelidine (Zimeldine) Cas 56775-88-3

Buy Zimelidine (Zimeldine) Cas 56775-88-3

Zimelidine (INN, BAN; brand names Zimeldine, Normud, Zelmid) , is an antidepressant medication of the selective serotonin reuptake inhibitor (SSRI) class, and the first SSRI antidepressant to be marketed.[2] It is a pyridylallylamine, and is structurally different from other antidepressants.

 

Buy Zimelidine (Zimeldine) Cas 56775-88-3

Buy Zimelidine (Zimeldine) Cas 56775-88-3

Buy Zimelidine (Zimeldine) Cas 56775-88-3

Buy Zimelidine (Zimeldine) Cas 56775-88-3

Buy Zimelidine (Zimeldine) Cas 56775-88-3

Buy Zimelidine (Zimeldine) Cas 56775-88-3

Buy Zimelidine (Zimeldine) Cas 56775-88-3

Buy Zimelidine (Zimeldine) Cas 56775-88-3

Buy Zimelidine (Zimeldine) Cas 56775-88-3

Buy Zimelidine (Zimeldine) Cas 56775-88-3

Buy Zimelidine (Zimeldine) Cas 56775-88-3

Buy Zimelidine (Zimeldine) Cas 56775-88-3

Buy Zimelidine (Zimeldine) Cas 56775-88-3

Buy Zimelidine (Zimeldine) Cas 56775-88-3

Buy Zimelidine (Zimeldine) Cas 56775-88-3

Zimelidine was developed in the late 1970s and early 1980s by Arvid Carlsson, Hans Corrodi and Peter Berntsson, who were then working for the Swedish company Astra AB. Their work began with a series of antihistamines known as pheniramines that were found to block both serotonin and noradrenaline reuptake, and among these, brompheniramine was identified as the most potent serotonin reuptake blocker and was therefore selected as the starting point for their synthesis program, ultimately leading to the invention of zimelidine as a derivative of brompheniramine.[4] Zimelidine was first sold in 1982.[5]

While zimelidine had a very favorable safety profile comparing to other commonly used antidepressants like tricyclic antidepressants at the time it was developed, within a year and a half of its introduction, rare case reports of Guillain–Barré syndrome emerged that appeared to be caused by the drug, prompting its manufacturer to withdraw it from the market.[2][5][6] Its withdrawal, due to this unpredictable neurological side effect, marked a swift end to its clinical use despite its pioneering efficacy.[2][4] After its withdrawal, it was succeeded by fluoxetine (derived from the antihistamine diphenhydramine) and fluvoxamine in that order, and the other SSRIs.

Mechanism of action

The mode of action is a strong reuptake inhibition of serotonin from the synaptic cleft. Postsynaptic receptors are not acted upon.

Product Name Zimelidine
CAS 56775-88-3
Synonyms
Molecular Formula C16H17BrN2
Molecular Weight 317.22 g/mol
Structural Identifiers
SMILES CN(C)CC=C(C1=CC=C(C=C1)Br)C2=CN=CC=C2
InChI InChI=1S/C16H17BrN2/c1-19(2)11-9-16(14-4-3-10-18-12-14)13-5-7-15(17)8-6-13/h3-10,12H,11H2,1-2H3/b16-9-
InChIKey OYPPVKRFBIWMSX-SXGWCWSVSA-N
Commercial & Availability
Standard Pack Sizes 25 mg / 50 mg / 100 mg / 500 mg / Bulk Custom
Availability In Stock
Custom Synthesis Available on request
Handling Information
Appearance Solid powder
Solubility In water, 190 mg/L at 25 °C (est)
Storage Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).

Structure & Identifiers


Interactive Chemical Structure Model






Zimelidine: First-in-Class SSRI for SERT Research


Zimelidine (CAS 56775-88-3) is a pyridylallylamine-class selective serotonin reuptake inhibitor (SSRI), historically recognized as the first SSRI antidepressant to enter clinical development [1]. It is structurally distinct from both tricyclic antidepressants (TCAs) and later SSRIs, featuring a (Z)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridinyl)-2-propen-1-amine core [2]. Its primary mechanism is potent and selective inhibition of the serotonin transporter (SERT), with significantly lower affinity for norepinephrine and dopamine transporters . Notably, zimelidine produces an active metabolite, norzimelidine, which contributes substantially to its in vivo pharmacology and extended half-life [3].

Selective SERT inhibitor for serotonergic pathway studies
Structurally distinct from TCAs and later SSRIs, enabling novel probe design
Active metabolite norzimelidine contributes to extended pharmacodynamic profile

Zimelidine Differentiation from SSRIs and TCAs


Zimelidine’s unique pharmacological profile prevents simple substitution with other SSRIs or TCAs. Unlike fluoxetine, which exhibits residual norepinephrine reuptake inhibition at higher concentrations, zimelidine demonstrates a markedly higher selectivity ratio for serotonin over norepinephrine uptake [1]. Compared to amitriptyline, a prototypical TCA, zimelidine shows negligible affinity for histamine H1, muscarinic acetylcholine, and α1-adrenergic receptors, eliminating anticholinergic and sedative side effects inherent to TCAs [2]. Furthermore, the contribution of its active metabolite norzimelidine introduces a distinct pharmacokinetic dynamic, with a half-life exceeding that of many comparator agents [3]. These distinctions are critical for researchers designing experiments where off-target pharmacology or metabolite activity must be tightly controlled or specifically exploited.

SSRIs like fluoxetine
SERT/NA selectivity ratios differ; noradrenergic background may not be comparable in sensitive assays.
TCAs such as amitriptyline
High H1 and muscarinic receptor affinity creates off-target effects absent in zimelidine, confounding receptor-specific readouts.
Metabolite profile mismatch
Norzimelidine’s extended half-life shifts pharmacokinetic dynamics; results from compounds lacking active metabolites may not transfer.

Zimelidine Quantitative Differentiation


Serotonin Uptake Selectivity vs. Fluoxetine

Zimelidine exhibits a significantly higher selectivity ratio for inhibiting serotonin (5-HT) uptake over noradrenaline (NA) uptake compared to fluoxetine. In rat brain synaptosome assays, zimelidine demonstrates an IC50 of 0.33 μM for 5-HT and 8.2 μM for NA, yielding a 5-HT/NA selectivity ratio of ~25-fold . In contrast, fluoxetine’s 5-HT/NA selectivity ratio is reported to be approximately 54-fold in some studies but can be as low as 14-fold in others, with a higher absolute potency for NA uptake inhibition (IC50 ~0.132 μM) than zimelidine [1]. This makes zimelidine a cleaner pharmacological tool for isolating serotonergic mechanisms with reduced noradrenergic interference.

5-HT vs NA Selectivity
Cross-study comparable
Zimelidine: IC50 5-HT 0.33 µM, NA 8.2 µM (ratio ~25)vs Fluoxetine: ratio ~2.5 (NA IC50 0.132 µM)
Supports cleaner serotonergic mechanism isolation
Rat synaptosome assays; selectivity context may vary across systems
Serotonin TransporterMonoamine UptakeSelectivity Profiling

H1 and Muscarinic Receptor Affinity vs. Amitriptyline

Zimelidine is virtually devoid of affinity for histamine H1 and muscarinic acetylcholine receptors, contrasting sharply with the TCA amitriptyline. While amitriptyline demonstrates high affinity for histamine H1 receptors (Kd = 0.5-1.1 nM) and muscarinic receptors (Ki = 11-24 nM), leading to sedation and anticholinergic effects [1], zimelidine showed negligible displacement of [3H]-mepyramine (H1) and [3H]-QNB (muscarinic) at concentrations up to 10 μM in human brain tissue [2]. This absence of receptor interaction is a

ZIMELIDINE DIHYDROCHLORIDE

ZIMELIDINE DIHYDROCHLORIDE price.
  • $150 – $2200
  • Product name: ZIMELIDINE DIHYDROCHLORIDE
  • CAS: 56775-88-3
  • MF: C16H17BrN2
  • MW: 317.22
  • EINECS:
  • MDL Number:MFCD00069358
  • Synonyms:cis-h102/09 ;cis-Zimelidine;H-102/09;(Z)-3-[1-(p-Bromophenyl)-3-(dimethylamino)propenyl]pyridine;(Z)-Zimelidine;3-(4-Bromophenyl)-N,N-dimethyl-3-(3-pyridinyl)-2-propen-1-amine;3-(p-bromophenyl)-n,n-dimethyl-3-(3-pyridyl)-allylamin ;Allylamine, 3-(p-bromophenyl)-N,N-dimethyl-3-(3-pyridyl)-

12 prices
Brand
  • aablocks
  • American Custom Chemicals Corporation
  • Biosynth
  • Medical Isotopes, Inc.
  • TRC
  • Usbiological
Package
  • 1mg
  • 2MG
  • 5MG
  • 10mg
  • 25mg
  • 50MG
Manufacturer Product number Product description Packaging Price Updated Buy
aablocks AA00EB0T Zimelidine 1mg $513 2026-05-28 Buy
American Custom Chemicals Corporation API0000889 ZIMELDINE 95.00% 5MG $786.5 2021-12-16 Buy
American Custom Chemicals Corporation API0000889 ZIMELDINE 95.00% 2MG $350 2021-12-16 Buy
American Custom Chemicals Corporation API0000889 ZIMELDINE 95.00% 50MG $1963.5 2021-12-16 Buy
Biosynth FZ28762 Zimeldine 1mg $150 2026-06-04 Buy
Biosynth FZ28762 Zimeldine 2mg $231.3 2026-06-04 Buy
Medical Isotopes, Inc. 14207 Zimeldine 25mg $2200 2021-12-16 Buy
TRC Z435000 Zimeldine 50mg $1455 2021-12-16 Buy
Usbiological 257163 Zimelidine dihydrochloride 10mg $310 2021-12-16 Buy
Usbiological 292107 Zimeldine 2mg $460 2021-12-16 Buy
Usbiological Z0445 Zimeldine ((Z)-3-(4-Bromophenyl)-N,N-dimethyl-3-(3-pyridinyl)-2-propen-1-amine, Zimelidine) ≥97% 10mg $1010 2026-06-04 Buy
Usbiological Z0445 Zimeldine ((Z)-3-(4-Bromophenyl)-N,N-dimethyl-3-(3-pyridinyl)-2-propen-1-amine, Zimelidine) ≥97% 5mg $579 2026-06-04 Buy

Properties

Melting point :193°C
Density :1.4039 (rough estimate)
refractive index :1.5500 (estimate)
storage temp. :Desiccate at RT
solubility :0.1 M HCl: 45 mg/mL
form :solid
color :white

Safety Information

Symbol(GHS):
Signal word:
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
Precautionary statements:

Zimeldine is a member of styrenes.
Zimelidine has been banned worldwide due to serious, sometimes fatal, cases of central and/or peripheral neuropathy known as Guillain-Barré syndrome and due to a peculiar hypersensitivity reaction involving many organs including skin exanthema, flu-like symptoms, arthralgias, and sometimes eosinophilia. Additionally, zimelidine was charged to cause an increase in suicidal ideation and/or attempts among depressive patients.
ZIMELDINE is a small molecule drug with a maximum clinical trial phase of IV and is indicated for major depressive disorder.
One of the SELECTIVE SEROTONIN REUPTAKE INHIBITORS formerly used for depression but was withdrawn worldwide in September 1983 because of the risk of GUILLAIN-BARRE SYNDROME associated with its use. (From Martindale, The Extra Pharmacopoeia, 29th ed, p385)

Source and Classification

Zimeldine is classified under the category of psychoactive drugs, specifically as an antidepressant. Its chemical structure is characterized by a pyridyl group linked to an allylamine moiety, which contributes to its pharmacological activity. As a member of the pyridylallylamine family, zimeldine’s mechanism involves the inhibition of serotonin and norepinephrine reuptake, thereby enhancing their availability in the synaptic cleft.

Synthesis Analysis

Methods and Technical Details

The synthesis of zimeldine typically involves several key steps:

  1. Starting Materials: The synthesis begins with commercially available precursors such as pyridine derivatives and allylamines.
  2. Reactions: The process often employs methods such as nucleophilic substitution and condensation reactions to form the final compound. For example, one common synthetic route involves the reaction of 3-pyridylacetaldehyde with an appropriate allylamine under acidic conditions.
  3. Purification: Following synthesis, purification techniques such as recrystallization or chromatography are utilized to isolate pure zimeldine.

Recent studies have explored variations in synthesis that include radiolabeling for imaging studies, enhancing understanding of zimeldine’s interaction with serotonin transporters  .

Molecular Structure Analysis

Structure and Data

Zimeldine has a complex molecular structure that can be represented as follows:

  • Chemical Formula: C15H16N2
  • Molecular Weight: Approximately 240.30 g/mol
  • Structural Features: The molecule consists of a pyridine ring connected to an allylic amine group. The stereochemistry is crucial for its biological activity, with specific configurations influencing its potency as a serotonin reuptake inhibitor.

The three-dimensional structure can be analyzed using computational chemistry methods to predict conformational preferences and interactions with biological targets  .

Chemical Reactions Analysis

Reactions and Technical Details

Zimeldine undergoes various chemical reactions that are significant for both its synthesis and metabolic pathways:

  1. Hydroxylation: Zimeldine can be metabolized in vivo to form hydroxylated derivatives, which may exhibit different pharmacological profiles.
  2. Dealkylation: This reaction leads to the formation of norzimeldine, a metabolite that retains some antidepressant activity.
  3. Reactivity with Electrophiles: The nitrogen atom in zimeldine’s amine group can participate in electrophilic substitution reactions, which can be exploited in further chemical modifications.

Research has shown that structural modifications can lead to varying degrees of serotonin transporter inhibition, impacting their therapeutic efficacy  .

Mechanism of Action

Process and Data

Zimeldine exerts its antidepressant effects primarily through the inhibition of serotonin reuptake at the synaptic cleft:

  1. Serotonin Transporter Inhibition: By blocking the serotonin transporter, zimeldine increases serotonin levels in the synaptic space, enhancing neurotransmission.
  2. Norepinephrine Reuptake Inhibition: It also affects norepinephrine levels, contributing to its mood-enhancing effects.
  3. Neurotransmitter Interaction: Studies indicate that zimeldine may modulate other neurotransmitter systems indirectly, although its primary action remains on serotonin and norepinephrine  .

Physical and Chemical Properties Analysis

Physical and Chemical Properties

Zimeldine exhibits several notable physical and chemical properties:

  • Appearance: Typically presented as a white crystalline solid.
  • Solubility: Soluble in organic solvents like ethanol and dimethyl sulfoxide but poorly soluble in water.
  • Melting Point: The melting point is around 160–165 °C.
  • Stability: Zimeldine is sensitive to light and moisture; thus, it should be stored in a cool, dry place.

These properties are crucial for formulation development in pharmaceutical applications  .

Applications

Scientific Uses

Although zimeldine was withdrawn from clinical use due to safety concerns, it remains relevant in scientific research:

  1. Neuroscience Studies: It serves as a model compound for studying serotonin transport mechanisms and receptor interactions.
  2. Drug Development: Researchers explore analogs of zimeldine for potential therapeutic applications in treating depression with improved safety profiles.
  3. Radiolabeled Analogs: These compounds are utilized in imaging studies to visualize serotonin transporters in vivo using single-photon emission computed tomography (SPECT) techniques  .

Properties

CAS Number

56775-88-3

Product Name

Zimelidine

IUPAC Name

(Z)-3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-3-ylprop-2-en-1-amine

Molecular Formula

C16H17BrN2

Molecular Weight

317.22 g/mol

InChI

InChI=1S/C16H17BrN2/c1-19(2)11-9-16(14-4-3-10-18-12-14)13-5-7-15(17)8-6-13/h3-10,12H,11H2,1-2H3/b16-9-

InChI Key

OYPPVKRFBIWMSX-SXGWCWSVSA-N

SMILES

Array

Solubility

In water, 190 mg/L at 25 °C (est)

Synonyms

H 102 09
H-102-09
H10209
Hydrochloride, Zimeldine
Hydrochloride, Zimelidine
Zelmid
Zimeldine
Zimeldine Hydrochloride
Zimelidin
Zimelidine
Zimelidine Hydrochloride

Canonical SMILES

CN(C)CC=C(C1=CC=C(C=C1)Br)C2=CN=CC=C2

Isomeric SMILES

CN(C)C/C=C(/C1=CC=C(C=C1)Br)\C2=CN=CC=C2

Description

Zimelidine Dihydrochloride, is a selective 5-HT uptake inhibitor. It modulates nociception and induces hyperglycemia in vivo, and is an orally active antidepressant

  1. Zimelidine (CAS 56775-88-3) | SERT Inhibitor | BenchChem

    Buy Zimelidine (CAS 56775-88-3) from BenchChem. High-selectivity SERT inhibitor; 25-fold 5-HT/NA selectivity. In stock for global …

  2. ZIMELIDINE DIHYDROCHLORIDE price,buy ZIMELIDINE …

    Zimelidine Dihydrochloride, is a selective 5-HT uptake inhibitor. It modulates nociception and induces hyperglycemia in vivo, and is …

  3. Buy Zimelidine (EVT-286972) | 56775-88-3 – evitachem.com

    Zimeldine is classified under the category of psychoactive drugs, specifically as an antidepressant. Its chemical structure is …

     

  4. ZIMELIDINE DIHYDROCHLORIDE | 56775-88-3 – ChemicalBook

     ZIMELIDINE DIHYDROCHLORIDE (CAS 56775-88-3) information, including chemical properties, structure, melting …

    • Density: 1.4039 (rough estimate)
    • refractive index: 1.5500 (estimate)
    • Melting point: 193°C
    • storage temp.: Desiccate at RT
  5. CAS 56775-88-3 Zimeldine – Analytical Products / Alfa Chemistry

    Home Products Analytical Standards Pharmaceuticals, Illicit Drugs & Alcohol Enzyme Activators, Inhibitors & Substrates Zimeldine

    CAS No : 56775-88-3| Chemical Name : Zimeldine| Product Name …

    Zimeldine is a pyridylallylamine, and is structurally different from other antidepressants.

    Zimelidine for Sale, Find Zimelidine Sale 56775-88-3 List – ECHEMI

    ECHEMI provides 16 top grade Zimelidine products for sale. Find Zimelidine 56775-88-3 you need according to certification and …

     

  6. Zimelidine | CAS 56775-88-3 | TargetMol | Biomol.com

    Buy Zimelidine, CAS: 56775-88-3, item number: TGM-T29216-25mg from TargetMol at Biomol!

  7. Zimeldine | 56775-88-3 | FZ28762 | Biosynth

    Buy Zimeldine (FZ28762 56775-88-3) online. Biosynth supplies catalog, bulk, and custom products for the life sciences and …

     

  8. Where to Buy CAS No.: 56775-88-3 | Zimeldine

    CAT Number: R007392 CAS Number: 56775-88-3 Molecular Formula: C₁₆H₁₇BrN₂ Molecular Weight: 317.22 Purity: ≥95% Inquiry …

Reviews

There are no reviews yet.

Be the first to review “Buy Zimelidine (Zimeldine) Cas 56775-88-3”

Your email address will not be published. Required fields are marked *

Shopping Cart